Skip to content

A randomized controlled clinical study of acupuncture combined with medicine in the treatment of ovarian hypofunction

A randomized controlled clinical study of acupuncture combined with medicine in the treatment of ovarian hypofunction

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035997
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian dysfunction

Interventions

Sponsors

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The DOR diagnostic criteria of western medicine and the diagnostic criteria of spleen and kidney deficiency syndrome of Traditional Chinese medicine, the patients who had regular menstruation in the past, had not used estrogen, Traditional Chinese medicine and acupuncture treatment in the recent 3 months, volunteered to participate in this study and insisted on treatment, and actively cooperated with the follow-up visits, were all included in this study after signing the informed consent.

Exclusion criteria

Exclusion criteria: 1. Aged 40 years; 2. Bilateral or unilateral ovariectomy or chemoradiotherapy caused DOR; 3. Chromosomal karyotype abnormality; 4. Congenital or acquired reproductive organ organic diseases and caused menstrual disorders; 5. For patients without menstrual symptoms, infertility caused by male factors, tubal factors, organic diseases of the reproductive organs and other factors other than THE DOR should be excluded; 6. Patients with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems, mental diseases and breast tumors; 7. Take estrogen, traditional Chinese medicine and acupuncture treatment history or history of amenorrhea within 3 months; 8. Is allergic to a variety of drugs or known to be allergic to the composition of the drug; 9. Pet-name failure to take prescribed drugs or to follow up regularly, unable to determine the efficacy or incomplete data affecting the efficacy.

Design outcomes

Primary

MeasureTime frame
AMH;Pregnancy rate, abortion rate;

Secondary

MeasureTime frame
TCM symptom and sign score;AFC and ovarian volume;T, FSH, LH, E2, PRL;

Countries

China

Contacts

Public ContactYang hong

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine

45113610@qq.com+86 13585517187

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026